Vein in Venice 2026 - Day one
Scientific Session
Workshop
Break
Special Session
Sala Perla - Lecture Hall
Sala Volpi - Workshop Room
09:00 Opening Ceremony
Speakers: L. Palombi, F. Martinelli, E. Mendoza, M. Whiteley, L. Kabnick, R. Rodriguez Carvajal
Session I
09:15–11:00 Chronic Venous Disease: we need to delve deeper!
- New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: from microvalves to clinical effectiveness (M. Lugli)
- The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease (A. Visonà)
- The Microbiota: does it play a role in CVD? (P. L. Antignani)
- Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities (G. Gastaldi)
- The cardiovascular impact of chronic venous disease (A.-S. Lensel)
- Clinical evidence and rationale of Mesoglycan to treat chronic venous disease and hemorrhoidal disease (G. Camporese)
- Chronic venous insufficiency in heart failure: reciprocal influence on cardiovascular health (E. Natale)
- Cellular senescence at the saphenofemoral junction (D. Mühlberger)
- Low-dose direct oral anticoagulants for secondary prevention – START2 Registry (R. Parisi)
- Does Artificial Intelligence bring new insights in diagnosing phlebological diseases? (S.-C. Matei)
10:00–11:00 Non-Thermal Procedures — Recorded Cases
- Non-rotational MOCA — T. Urbanek
- Glue Occlusion — K. Bozkurt (Istanbul, Turkey)
- Rotational MOCA — F. Martinelli
- Glue direct puncture for recurrent varicose veins — D. Konthotanassis
- ScleroSafe Device — L. Kabnick
11:00–11:30 Coffee Break
Session II
11:30–13:30 2026 ERA in the Surgical Management of Deep Vein System and Pelvic Veins Disease
- Endovascular treatment of Deep Vein Thrombosis: evidence and controversies (E. Avgerinos)
- Current evidence in chronic occlusive venous disease treatments (M. Lugli)
- Last generation venous stents: evidence, indications and patient selection (R. K. Tripathi)
- Current management of pulmonary embolism: indications and treatment options (M. Dumantepe)
- My plan treating pelvic vein insufficiency: compression vs primary incompetence (R. Rodriguez Carvajal)
- How I do it: algorithm treating acute Deep Vein Thrombosis (D. Baccellieri)
- Inferior Vena Cava chronic occlusions: tips & tricks for a successful approach (H. Jalaie)
- Multiple vein compression syndromes and treatment options (K. Kim)
11:30–12:30 Vein in Venice & Vein and Lymphatic University
- Pres.: L. Kabnick, V. Canata
- Perforators and Glue: efficacy and complications — K. Bozkurt (Turkey)
- Discussant: L. Palombi (Italy)
- Grey zones in endothermal ablations — D. Konthotanassis (Italy)
- Discussant: G. Stalnikiewicz (France)
- Prophylaxis after varicose vein surgery — A. H. Davies (UK)
- Discussant: T. Urbanek (Poland)
- EHIT, EFIT, EGIT, EHIFU, EMOCA: what do we know? — L. Kabnick (USA)
- Discussant: S. R. Pandey
- Why use HIFU (thermal) — P. Casoni
- Discussant: M. Whiteley
- Effective prophylaxis of visual and neurological disturbances with anti-endothelin drugs — A. Frullini (Germany)
- Discussant: E. Mendoza
12:00–13:00 Workshop Neopharmedal (NO CME)
13:30–14:00 Lunch Break
Session III
14:00–15:30 Sclerotherapy: let’s try to standardize the treatment!
- Master Lecture — The Role of Sclerotherapy in Venous Disease (L. Tessari)
- GSV and SSV treatment: what literature and guidelines tell us (L. Santoro)
- The VD(L) system for the standardization of venous treatment (A. Frullini)
- Automated device for reticular and spider veins: for the motion (E. Roche)
- Automated device for reticular and spider veins: against the motion (M. Sica, online)
- Hemorrhoidal pathology: when to treat with sclerotherapy and when not (Ronconi)
- Post-treatment directions: is there really clarity? (Guarnaccia)
- Sclerotherapy with tourniquet: advantages (V. Canata)
14:00–15:00 Endovascular Management of DVT — Recorded Cases
- Pres.: R. Rodriguez Carvajal, D. Baccellieri, M. Lugli
- TEP & DVT in pregnancies — M. Dumantepe
- Ilio-caval thrombosis — H. Jalaie
- Ilio-femoral thrombosis — D. Baccellieri
- In-stent thrombosis — E. Avgerinos
- Venous thoracic outlet syndrome (vTOS) — R. Rodriguez Carvajal
Session IV
15:45–17:30 Thermal Ablation for Varicose Vein Treatment
- Results from TOTEM trial (L. Palombi)
- Laser flush ligation: indications and results (L. Velicka)
- Comparative results EVLA 1940 nm vs 1470 nm (J. Szczepansky)
- Late pulmonary embolism after endovenous thermal ablation (M. Greco)
- Venous wall effects using VELEX, EVLA and foam sclerotherapy (M. Salerno)
- Early outcomes of third-generation ClosureFast RFA (D. Baccellieri)
- Complications of endovenous thermal ablation (L. Kabnick)
- Microwave ablation of saphenous vein insufficiency (M. S. Whiteley)
- To treat or not to treat competent AASV with refluxive GSV? (T. Hirsch)
- Refined delivery of tumescent anesthesia in EVLA (T. M. Massimi)
16:00–17:00 Sclerotherapy — Recorded Cases
- Pres.: J. Wonguk, V. Ferreira
- G. Alongi
- E. Roche
- A. Frullini
- R. Rodriguez Carvajal
- V. Ferreira
Session V
17:45–19:00 Non-Thermal Ablation & HIFU for Varicose Vein Treatment
- Non-rotational mechanochemical ablation in chronic venous ulceration (M. Maga)
- Real-world safety and efficiency of treating varicose veins with cyanoacrylate glue (D. Konthotanassis)
- Vein diameter, obesity and recanalization after mechanochemical ablation (A. Griso)
- Mechanochemical endovenous ablation using Flebogrif: systematic review (T. Urbanek)
- Contemporary management of SSV incompetence — FOVELASS study (C. Hamel-Desnos)
- HIFU: patient selection criteria (R. Rodriguez Carvajal)
- HIFU-pain study: anaesthesia protocols (P. Casoni)
- What are the new devices in the non-thermal family (L. Kabnick)